Corrected on Apr 27, 2020.
Source: the publisher, via Crossref · checked Oct 31, 2026 · Read the notice
- Corrected on Mar 21, 2023. Source: the publisher, via Crossref · Read the notice
- Corrected on Feb 11, 2020. Source: the publisher, via Crossref · Read the notice
Comprehensive molecular characterization of mitochondrial genomes in human cancers
Yuan Yuan, Young Seok Ju, Youngwook Kim and 97 more
Nature Genetics · 2020 · CC BY
Abstract
Mitochondria are essential cellular organelles that play critical roles in cancer. Here, as part of the International Cancer Genome Consortium/The Cancer Genome Atlas Pan-Cancer Analysis of Whole Genomes Consortium, which aggregated whole-genome sequencing data from 2,658 cancers across 38 tumor types, we performed a multidimensional, integrated characterization of mitochondrial genomes and related RNA sequencing data. Our analysis presents the most definitive mutational landscape of mitochondrial genomes and identifies several hypermutated cases. Truncating mutations are markedly enriched in kidney, colorectal and thyroid cancers, suggesting oncogenic effects with the activation of signaling pathways. We find frequent somatic nuclear transfers of mitochondrial DNA, some of which disrupt therapeutic target genes. Mitochondrial copy number varies greatly within and across cancers and correlates with clinical variables. Co-expression analysis highlights the function of mitochondrial genes in oxidative phosphorylation, DNA repair and the cell cycle, and shows their connections with clinically actionable genes. Our study lays a foundation for translating mitochondrial biology into clinical applications.
References 54
- 1.
Schon EA, DiMauro S, Hirano M. Human mitochondrial DNA: roles of inherited and somatic mutations. Nat. Rev. Genet. 2012;13:878-890.
Not in our library10.1038/nrg3275
- 2.
Smeitink J, van den Heuvel L, DiMauro S. The genetics and pathology of oxidative phosphorylation. Nat. Rev. Genet. 2001;2:342-352.
Not in our library10.1038/35072063
- 3.
Anderson S, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290:457-465.
Not in our library10.1038/290457a0
- 4.
Brandon M, Baldi P, Wallace DC. Mitochondrial mutations in cancer. Oncogene. 2006;25:4647-4662.
Not in our library10.1038/sj.onc.1209607
- 5.
Zong WX, Rabinowitz JD, White E. Mitochondria and cancer. Mol. Cell. 2016;61:667-676.
Not in our library10.1016/j.molcel.2016.02.011
- 6.
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646-674.
Not in our library10.1016/j.cell.2011.02.013
- 7.
Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407:770-776.
Not in our library10.1038/35037710
- 8.
Larman TC, et al. Spectrum of somatic mitochondrial mutations in five cancers. Proc. Natl Acad. Sci. USA. 2012;109:14087-14091.
Not in our library10.1073/pnas.1211502109
- 9.
- 10.
Stewart JB, et al. Simultaneous DNA and RNA mapping of somatic mitochondrial mutations across diverse human cancers. PLoS Genet. 2015;11:e1005333.
Not in our library10.1371/journal.pgen.1005333
- 11.
Ju YS, et al. Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells. Genome Res. 2015;25:814-824.
Not in our library10.1101/gr.190470.115
- 12.
- 13.
Hopkins JF, et al. Mitochondrial mutations drive prostate cancer aggression. Nat. Commun. 2017;8:656.
Not in our library10.1038/s41467-017-00377-y
- 14.
- 15.
The Cancer Genome Atlas Research Network et al. The Cancer Genome Atlas pan-cancer analysis project. Nat. Genet.45, 1113–1120 (2013).
Not in our library10.1038/ng.2764
- 16.
- 17.
- 18.
- 19.
Costello M, et al. Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation. Nucleic Acids Res. 2013;41:e67.
Not in our library10.1093/nar/gks1443
- 20.
Lawrence MS, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499:214-218.
Not in our library10.1038/nature12213
- 21.
- 22.
Tanaka M, Ozawa T. Strand asymmetry in human mitochondrial DNA mutations. Genomics. 1994;22:327-335.
Not in our library10.1006/geno.1994.1391
- 23.
Zheng W, Khrapko K, Coller HA, Thilly WG, Copeland WC. Origins of human mitochondrial point mutations as DNA polymerase γ-mediated errors. Mutat. Res. 2006;599:11-20.
Not in our library10.1016/j.mrfmmm.2005.12.012
- 24.
Alexandrov LB, et al. Clock-like mutational processes in human somatic cells. Nat. Genet. 2015;47:1402-1407.
Not in our library10.1038/ng.3441
- 25.
Coller HA, et al. High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat. Genet. 2001;28:147-150.
Not in our library10.1038/88859
- 26.
The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330-337.
Not in our library10.1038/nature11252
- 27.
The Cancer Genome Atlas Research Network et al. Integrated genomic characterization of endometrial carcinoma. Nature497, 67–73 (2013).
Not in our library10.1038/nature12113
- 28.
- 29.
Pak JW, Vang F, Johnson C, McKenzie D, Aiken JM. MtDNA point mutations are associated with deletion mutations in aged rat. Exp. Gerontol. 2005;40:209-218.
Not in our library10.1016/j.exger.2004.12.005
- 30.
Davis CF, et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014;26:319-330.
Not in our library10.1016/j.ccr.2014.07.014
- 31.
Caro P, et al. Mitochondrial DNA sequences are present inside nuclear DNA in rat tissues and increase with age. Mitochondrion. 2010;10:479-486.
Not in our library10.1016/j.mito.2010.05.004
- 32.
- 33.
Srinivasainagendra V, et al. Migration of mitochondrial DNA in the nuclear genome of colorectal adenocarcinoma. Genome Med. 2017;9:31.
Not in our library10.1186/s13073-017-0420-6
- 34.
Cui H, et al. Association of decreased mitochondrial DNA content with the progression of colorectal cancer. BMC Cancer. 2013;13:110.
Not in our library10.1186/1471-2407-13-110
- 35.
- 36.
Van Osch FH, et al. Mitochondrial DNA copy number in colorectal cancer: between tissue comparisons, clinicopathological characteristics and survival. Carcinogenesis. 2015;36:1502-1510.
Not in our library10.1093/carcin/bgv151
- 37.
McBride HM, Neuspiel M, Wasiak S. Mitochondria: more than just a powerhouse. Curr. Biol. 2006;16:R551-R560.
Not in our library10.1016/j.cub.2006.06.054
- 38.
Vyas S, Zaganjor E, Haigis MC. Mitochondria and cancer. Cell. 2016;166:555-566.
Not in our library10.1016/j.cell.2016.07.002
- 39.
Lott MT, et al. mtDNA variation and analysis using mitomap and mitomaster. Curr. Protoc. Bioinformatics. 2013;44:1.23.1-1.23.26.
Not in our library10.1002/0471250953.bi0123s44
- 40.
Mercer TR, et al. The human mitochondrial transcriptome. Cell. 2011;146:645-658.
Not in our library10.1016/j.cell.2011.06.051
- 41.
- 42.
Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA. 2005;102:15545-15550.
Not in our library10.1073/pnas.0506580102
- 43.
Koczor CA, et al. Mitochondrial DNA damage initiates a cell cycle arrest by a Chk2-associated mechanism in mammalian cells. J. Biol. Chem. 2009;284:36191-36201.
Not in our library10.1074/jbc.m109.036020
- 44.
Ojala D, Montoya J, Attardi G. tRNA punctuation model of RNA processing in human mitochondria. Nature. 1981;290:470-474.
Not in our library10.1038/290470a0
- 45.
Joshi S, et al. The genomic landscape of renal oncocytoma identifies a metabolic barrier to tumorigenesis. Cell Rep. 2015;13:1895-1908.
Not in our library10.1016/j.celrep.2015.10.059
- 46.
Gasparre G, Romeo G, Rugolo M, Porcelli AM. Learning from oncocytic tumors: why choose inefficient mitochondria? Biochim. Biophys. Acta. 2011;1807:633-642.
Not in our library10.1016/j.bbabio.2010.08.006
- 47.
Clayton DA, Doda JN, Friedberg EC. The absence of a pyrimidine dimer repair mechanism in mammalian mitochondria. Proc. Natl Acad. Sci. USA. 1974;71:2777-2781.
Not in our library10.1073/pnas.71.7.2777
- 48.
Haradhvala NJ, et al. Mutational strand asymmetries in cancer genomes reveal mechanisms of DNA damage and repair. Cell. 2016;164:538-549.
Not in our library10.1016/j.cell.2015.12.050
- 49.
Bess AS, Crocker TL, Ryde IT, Meyer JN. Mitochondrial dynamics and autophagy aid in removal of persistent mitochondrial DNA damage in Caenorhabditis elegans. Nucleic Acids Res. 2012;40:7916-7931.
Not in our library10.1093/nar/gks532
- 50.
Koboldt DC, et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012;22:568-576.
Not in our library10.1101/gr.129684.111
- 51.
Kent WJ. BLAT—the BLAST-like alignment tool. Genome Res. 2002;12:656-664.
Not in our library10.1101/gr.229202
- 52.
Simone D, Calabrese FM, Lang M, Gasparre G, Attimonelli M. The reference human nuclear mitochondrial sequences compilation validated and implemented on the UCSC genome browser. BMC Genomics. 2011;12:517.
Not in our library10.1186/1471-2164-12-517
- 53.
Van Loo P, et al. Allele-specific copy number analysis of tumors. Proc. Natl Acad. Sci. USA. 2010;107:16910-16915.
Not in our library10.1073/pnas.1009843107
- 54.
Van Allen EM, et al. Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nat. Med. 2014;20:682-688.
Not in our library10.1038/nm.3559
Cited by papers we hold 10
- Prognostic genome and transcriptome signatures in colorectal cancers · 2024No notice
- Role of mitochondrial alterations in human cancer progression and cancer immunity · 2023No notice
- Curcumin derivative 1, 2-bis [(3E, 5E)-3, 5-bis [(2-chlorophenyl) methylene]-4-oxo-1-piperidyl] ethane-1, 2-dione (ST03) induces mitochondria mediated apoptosis in ovarian cancer cells and inhibits tumor progression in EAC mouse model · 2022Not checked
- Nuclear-embedded mitochondrial DNA sequences in 66,083 human genomes · 2022No notice
- CRISPR-free base editors with enhanced activity and expanded targeting scope in mitochondrial and nuclear DNA · 2022No notice
- The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies · 2021No notice
- Mitochondrial metabolism as a potential therapeutic target in myeloid leukaemia · 2021No notice
- Divergent mutational processes distinguish hypoxic and normoxic tumours · 2020Corrected
- Accurate mapping of mitochondrial DNA deletions and duplications using deep sequencing. · 2020Not checked
- Pan-cancer analysis of whole genomes · 2020Corrected
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.